Novel conjugates, preparation thereof, and therapeutic use thereof

Details for Australian Patent Application No. 2010267917 (hide)

Owner Sanofi

Inventors Bouchard, Herve; Brun, Marie-Priscille; Commercon, Alain; Zhang, Jidong

Agent Watermark

Pub. Number AU-A-2010267917

PCT Pub. Number WO2011/001052

Priority 0903170 29.06.09 FR; 0905651 25.11.09 FR

Filing date 20 May 2010

Wipo publication date 6 January 2011

International Classifications

C07D 273/08 (2006.01) Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/001052 Priority application(s): WO2011/001052

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010267924-Oxidative stress resistant bifidobacteria

2010267910-Analysis and assay of glycated hemoglobins by capillary electrophoresis, buffer compositions, and kits for capillary electrophoresis